| 发明名称 |
USE OF METHYLPHENIDATE OR A PHARMACEUTICALLY ACCEPTABLE SALTTHEREOF |
| 摘要 |
A dosage form and a method are disclosed and claimed for administering a dru g in a sustained and constantly ascending rate per unit time to provide an intended therapeutic effect while concomitantly lessening the development of unwanted effects.
|
| 申请公布号 |
CA2264852(C) |
申请公布日期 |
2005.11.01 |
| 申请号 |
CA19972264852 |
申请日期 |
1997.09.16 |
| 申请人 |
ALZA CORPORATION |
发明人 |
CHRISTOPHER, CAROL A.;GUINTA, DIANE R.;SAKS, SAMUEL R.;GUPTA, SUNEEL K. |
| 分类号 |
A61K9/22;A61K9/20;A61K9/24;A61K9/50;A61K9/70;A61K31/00;A61K31/136;A61K31/137;A61K31/421;A61K31/4458;A61K47/30;A61P25/26;(IPC1-7):A61K31/445;A61K9/26 |
主分类号 |
A61K9/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
